Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in and
1 other channel

Journal Scan / Research · {not yet published}

Risk of Hypertension in Patients With MS Treated With Teriflunomide vs Dimethyl Fumarate

Multiple Sclerosis (Houndmills, Basingstoke, England)

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Ahmed Obeidat MD, PhD

Multiple Sclerosis (Houndmills, Basingstoke, England)
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark
Mult. Scler. 2024 Dec 04;[EPub Ahead of Print], E Framke, F Sellebjerg, M Kant, M Stilund, HB Jensen, Z Illes, N Asgari, T Sejbaek, LC Roug, MB Jensen, J Schäfer, PV Rasmussen, JR Christensen, A Weglewski, S Prakash, M Magyari

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.